Bone Biologics (BBLG) SEC Filings: History & Chart

Bone Biologics Corporation(BBLG)

Biotechnology · Burlington, MA

$0.48-0.01 (-1.17%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Bone Biologics Corporation

Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.

Burlington, MA

2 employees

www.bonebiologics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jeffrey Frelick

View full financials

Form	Filing Date	Accepted	Document
4	Sep 30, 2026	Sep 30, 2026	View filing
4	Sep 30, 2026	Sep 30, 2026	View filing
4	Sep 30, 2026	Sep 30, 2026	View filing
4	Sep 30, 2026	Sep 30, 2026	View filing
8-K	Sep 29, 2026	Sep 29, 2026	View filing
8-K	Sep 16, 2026	Sep 16, 2026	View filing
DEF 14A	Aug 28, 2026	Aug 28, 2026	View filing
PRE 14A	Aug 18, 2026	Aug 18, 2026	View filing
10-Q	Aug 14, 2026	Aug 14, 2026	View filing
EFFECT	Jul 24, 2026	Jul 27, 2026	View filing
424B3	Jul 24, 2026	Jul 24, 2026	View filing
8-K	Jul 23, 2026	Jul 23, 2026	View filing
DEFA14A	Jul 20, 2026	Jul 20, 2026	View filing
S-3	Jul 17, 2026	Jul 17, 2026	View filing
8-K	Jul 16, 2026	Jul 16, 2026	View filing
8-K	Jul 9, 2026	Jul 9, 2026	View filing
ARS	Jul 2, 2026	Jul 2, 2026	View filing
DEFA14A	Jul 2, 2026	Jul 2, 2026	View filing
DEF 14A	Jul 2, 2026	Jul 2, 2026	View filing
10-Q	May 14, 2026	May 14, 2026	View filing
8-K	Mar 13, 2026	Mar 13, 2026	View filing
424B5	Mar 13, 2026	Mar 13, 2026	View filing
10-K	Mar 2, 2026	Mar 2, 2026	View filing
4	Jan 21, 2026	Jan 21, 2026	View filing
4	Jan 21, 2026	Jan 21, 2026	View filing
8-K	Jan 8, 2026	Jan 8, 2026	View filing
10-Q	Nov 14, 2025	Nov 14, 2025	View filing
SC 13G/A	Nov 7, 2025	Nov 7, 2025	View filing
S-8	Sep 26, 2025	Sep 26, 2025	View filing
8-K	Sep 4, 2025	Sep 4, 2025	View filing

SEC Filings

Recent Filings